References
- 1. Young NS, Brown KE. Mechanisms of disease: Parvovirus B19. N Engl J Med. 2004;350(6):586-97.
- 2. Sim JY, Chang LY, Chen JM, Lee PI, Huang LM, Lu CY. Human parvovirus B19 infection in patients with or without underlying diseases. J Microbiol Immunol Infect. 2019;52(4):534-41.
- 3. Servey JT. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007;75:373-6.
- 4. Brown KE. Parvoviruses. In: Viral infections of humans: Epidemiology and control. Springer US; 2014:629-49.
- 5. Ornoy A, Ergaz Z. Parvovirus B19 infection during pregnancy and risks to the fetus. Birth Defects Res. 2017;109:311-23.
- 6. de Jong EP, Walther FJ, Kroes ACM, Oepkes D. Parvovirus B19 infection in pregnancy: New insights and management. Prenat Diagn. 2011;31:419-25.
- 7. Seitz R. Parvovirus B19-revised. Transfus Med Hemotherapy. 2010;37:339-50.
- 8. Dijkmans AC, De Jong EP, Dijkmans BAC, Lopriore E, Vossen A, Walthere FJ, et al. Parvovirus B19 in pregnancy: Prenatal diagnosis and management of fetal complications. Curr Opin Obstet Gynecol. 2012;24:95-101.
- 9. Soltani S, Zakeri A, Tabibzadeh A, Zandi M, Ershadi E, Akhavan Rezayat S, et al. A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients. Trop Med Health. 2020;48(1):96.
- 10. Landry ML. Parvovirus B19. Microbiol Spectr. 2016;4(3).
- 11. Manaresi E, Gallinella G. Advances in the development of antiviral strategies against parvovirus B19. Viruses. 2019;11(7):659.
- 12. Servant-Delmas A, Morinet F. Update of the human parvovirus B19 biology. Transfus Clin Biol. 2016;23(1):5-12.
- 13. Crane J, Mundle W, Boucoiran I, Gagnon R, Bujold E, Basso M, et al. Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Canada. 2014;36(12):1107-16.
- 14. Lamont RF, Sobel JD, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, et al. Parvovirus B19 infection in human pregnancy. Int J Obstet Gynaecol. 2011;118:175-86.
- 15. Rosenstein RK, Rosenstein PK, Kramer N, Rosenstein ED. Healthcare-associated transmission of parvovirus B19 arthropathy. Bull Hosp Joint Dis. 2020;78(2):140-3.
- 16. Ismail KM, Kilby MD. Human parvovirus B19 infection and pregnancy. Obstet Gynaecol. 2003;5(1):4-9.
- 17. Tidman ASM, Fatima R. An unusual cutaneous manifestation of parvovirus B19 infection: papular – purpuric gloves-and-socks syndrome and petechial bathing trunk eruption. Clin Exp Dermatol. 2020;45:341-2.
- 18. Family A, Allmon A, Deane K, Martin KL. Common skin rashes in children. Am Fam Physician. 2015;92. [http://www.aafp.org/afp]
- 19. Carlesimo M, Palese E, Mari E, Panasiti V, Picarelli A, Rossi A, et al. Gloves and socks syndrome caused by parvovirus B19 infection. Dermatol Online J. 2006;12(6):19.
- 20. Santonja C, Nieto-González G, Santos-Briz Á, De Las Nieves Gutiérrez Zufiaurre M, Cerroni L, Kutzner H, et al. Immunohistochemical detection of parvovirus B19 in “gloves and socks” papular purpuric syndrome: Direct evidence for viral endothelial involvement. Report of three cases and review of the literature. Am J Dermatopathol. 2011;33(8):790-5.
- 21. Ware AJ, Moore T. Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;32(7):E122-3.
- 22. Izquierdo-Blasco J, Salcedo Allende MT, Codina Grau MG, Gran F, Martínez Sáez E, Balcells J. Parvovirus B19 myocarditis: Looking beyond the heart. Pediatr Dev Pathol. 2020;23(2):158-62.
- 23. Verdonschot J, Hazebroek M, Merken J, Debing Y, Dennert R, Brunner-La Rocca HP, et al. Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature. Eur J Heart Fail. 2016;18:1430-41.
- 24. Molina KM, Garcia X, Denfield SW, Fan Y, Morrow WR, Towbin JA, et al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013;34(2):390-7.
- 25. Bihari C, Rastogi A, Saxena P, Rangegowda D, Chowdhury A, Gupta N, et al. Parvovirus B19 associated hepatitis. Hepat Res Treat. 2013;2013:1-9.
- 26. Watanabe T. Acute encephalitis and encephalopathy associated with human parvovirus B19 infection in children. World J Clin Pediatr. 2015;4(4):126.
- 27. Barah F, Whiteside S, Batista S, Morris J. Neurological aspects of human parvovirus B19 infection: A systematic review. Rev Med Virol. 2014;24:154-68.
- 28. Shimohata H, Higuchi T, Ogawa Y, Fujita S, Nagai M, Imaizumi M, et al. Human parvovirus B19-induced acute glomerulonephritis: A case report. Ren Fail. 2013;35(1):159-62.
- 29. Karami A, Hoseini SL, Ramazani A, Emadi P, Gholami H, Hoseini SM. Prevalence of Parvovirus B19 infection by serology and PCR in pregnant women referring to Obstetrics and Gynecology Clinic. J Natl Med Assoc. 2020;112(1):91-6.
- 30. Giorgio E, De Oronzo MA, Iozza I, Di Natale A, Cianci S, Garofalo G, et al. Parvovirus B19 during pregnancy: a review. J Prenat Med. 2010;4(4):63-6.
- 31. Bonvicini F, Bua G, Gallinella G. Parvovirus B19 infection in pregnancy – awareness and opportunities. Curr Opin Virol. 2017;27: 8-14.
- 32. Barlinn R, Trogstad L, Rollag H, Frøen F, Magnus P, Dudman SG. Parvovirus B19 DNAemia in pregnant women in relation to perinatal death: A nested case-control study within a large population-based pregnancy cohort. Acta Obstet Gynecol Scand. 2020;99(7):856-64.
- 33. Attwood LO, Holmes NE, Hui L. Identification and management of congenital parvovirus B19 infection. Prenat Diagn. 2020;40:1722-31.
- 34. Markowska A, Połczyńska-Kaniak E. Zakażenie parwowirusem B19 w czasie ciąży. Ginekol Dypl. 2011;(4):31-7.
- 35. Silingardi E, Santunione AL, Rivasi F, Gasser B, Zago S, Garagnani L. Unexpected intrauterine fetal death in parvovirus B19 fetal infection. Am J Forensic Med Pathol. 2009;30(4):394-7.
- 36. Grabarczyk P, Kalińska A, Litwińska B, Celewicz Z, Dębska M, Nowakowska D, et al. Diagnostyka laboratoryjna zakażenia parvowirusem B19 u kobiet w ciąży. Warszawa: Krajowa Izba Diagnostów Laboratoryjnych; 2014.
- 37. Melamed N, Whittle W, Kelly EN, Windrim R, Seaward PGR, Keunen J, et al. Fetal thrombocytopenia in pregnancies with fetal human parvovirus-B19 infection. Am J Obstet Gynecol. 2015;212(6): 793.e1-793.e8.
- 38. Pawelec K, Zdziechowicz I, Siwicka A, Matysiak M. Parwowirus B19 jako przyczyna przejściowej anemii aplastycznej – opis przypadku. Postępy Nauk Med. 2016;8:581-3.
- 39. Costa ML, de Moraes Nobrega G, Antolini-Tavares A. Key Infections in the placenta. Obstet Gynecol Clin N Am. 2020;47:133-46.
- 40. Rogo LD, Mokhtari-Azad T, Kabir MH, Rezaei F. Human parvovirus B19: A review. Acta Virologica. 2014;58:199-213.